ABSTRACT T lymphocytes express a unique I-A subregioncontrolled surface molecule that is not expressed on B lymphocytes. We produced antisera and monoclonal antibodies recognizing this structure. Exhaustive B cell adsorption of (A.TH x BIO.HTT)Fj antiserum, produced against activated A.TL T cells, left antibodies that bind an I-Ak specificity on some B10.A(4R) T lymphocytes (11 ± 2%, mean ± SEM). Similarly, exhaustive B cell adsorption of (A/J x BIO.MBR)F1 antiserum, produced against activated BIO.A(5R) cells, left antibodies specific for an I-A determinanton B10.A(5R) Tcells (17 ± 2%). We fused A.TL-immune (ATH x BIO.HTT)F1 splenocytes with NS-1 myeloma cells and identified antibody-producing hybrid cells by a fluorescent enzyme-linked immunosorbent microassay described herein. Eight monoclonal antibodies were selected; these lyse 7-26% of peripheral T cells from I-Ak strains. Thymocytes and bone marrow cells do not express the I-Ak T cell determinant. Exhaustive B cell adsorption did not remove I-Ak T cell-specific monoclonal antibodies.
sorption did not remove I-Ak T cell-specific monoclonal antibodies. Specific immune responsiveness to foreign antigens is determined by genetic and environmental influences. Immune response (Ir) genes in mice, which defined the major histocompatibility complex I-region, provide the opportunity to investigate a molecular basis for immune regulation (1, 2) . The I region encompasses Ir genes and genes controlling immune suppression, cellular interactions, cell-mediated anti-viral immunity, maturational processes involved in self-nonself discrimination, and other traits (3) (4) (5) (6) (7) .
A prerequisite to explaining gene function is to identify the gene products involved. Ta antigens, the products of I-region genes, occur on most B lymphocytes, macrophages, and some other cells, including a T lymphocyte subpopulation (8) (9) (10) (11) (12) (13) . Absorption and immunoprecipitation experiments do not distinguish T cell from B cell Ta molecules (14, 15) . Seventeen Taspecific monoclonal antibodies have been reported; none lyse T cells in cytotoxicity assays or stain T cells by immunofluorescent techniques (16) (17) (18) . Ta antigens have been reviewed (8) (9) (10) (11) .
A second family of I-region gene products, Tat molecules, occurs on some T lymphocytes and regulatory T cell products (19) (20) (21) (22) (23) but not on B lymphocytes or B cell products (20, (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Tat determinants are observed primarily in studies ofregulatory T lymphocyte function (19) (20) (21) (22) (23) 26 ). An I-J subregion structure is characteristic of suppressor T cells and T cell-derived suppressor factors (20) (21) (22) . Tat.W40, an ITJk specificity, is present on mature peripheral T cells, but is absent from thymocytes (24) . Monoclonal antibodies reactive with I-J products have been reported (27, 28) . A second Tat molecule, lat.W46, is controlled by a gene mapping between the I-J and I-E subregions (25) . Finally, a third Iat antigen, Iat.W41, the Ia-7 locus product, maps between H-2K and I-A (29) .
Helper T lymphocytes and their regulatory mediators may express an I-A subregion-encoded determinant that is not on B lymphocytes (19, 22, 23, 26) . Two problems hamper the characterization of I-A-encoded T cell molecules. First, I-A subregion-specific antisera contain antibodies against Ia molecules. Exhaustive B cell absorption leaves antibodies that destroy helper T cells but cannot be detected by cytotoxicity (23 Blood collected from the retro-orbital sinus 3-5 days after Abbreviations: Ir, immune response; Ia, I-region associated; Pi/NaCl, phosphate-buffered saline; ELISA, enzyme-linked immunosorbent assay; DME medium, Dulbecco's modified Eagle's medium; P-GZ-RAMIg, /3-galactosidase coupled to rabbit anti-mouse immunoglobulin.
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boosting was clotted and centrifuged, and serum aliquots were stored at -59TC. Anti-Thy-1.2 serum was produced according to Reif and Allen (31) . Goat anti-mouse immunoglobulin was prepared in our laboratory (25 0 .05 g of dimethyl sufoxide per ml) was added slowly with swirling over 3 min, the tube was immersed for 90 sec in a 370C bath, and DME medium (20 ml) was added dropwise with swirling over 2 min. The tube was filled with DME medium and centrifuged, the supernatant was discarded, and the cell pellet was resuspended gently in supplemented DME medium with 60 1M hypoxanthine and 20 uM thymidine (5 ml). After a 2-hr incubation (370C, 7.5% CO2 in air), cells were pelleted and resuspended in supplemented DME medium with 10% fetal calf serum, hypoxanthine, thymidine, and 0.5 ptM aminopterin (48 ml), and 0.05 ml was put into each well of 10 96-well microtiter plates previously prepared with peritoneal exudate cells (3,000 cells per well) in 0.15 ml of medium with hypoxanthine, thymidine, and aminopterin. Growth in this medium was continued for 3 weeks, whereafter cells were grown 2 weeks in medium with hypoxanthine and thymidine (36) . Plates were scored for hybridoma growth 14 days after fusion; samples withdrawn from growth-positive wells were assayed by ELISA, microcytotoxicity assay, or both. Antibody-producing cultures with 103 cells were transferred into culture dishes containing 2 X 104 peritoneal exudate cells in 1 ml of supplemented DME medium with 10% fetal calf serum. Expanded cultures were sampled after 5 days and assays for antibody-producing cells repeated. Selected cells were cloned.
Cell Cloning by Limiting Dilution. Feeder cell layers were prepared by plating peritoneal macrophages in 96-well microtiter plates (2 x 103 cells in 0.1 ml of supplemented DME medium with 10% fetal calf serum per well). Mid-logarithmicphase hybridoma cells were suspended in DME medium with 10% fetal calf serum (25 cells per ml) and 0.1 ml was dispensed into each of 36 wells. Cells were diluted to 5 cells per ml and 0.1 ml was dispensed into a second set of 36 wells. Finally, cells were diluted to 1 cell per ml and 0.1 ml was dispensed into the remaining 24 wells of a 96-well plate. Twelve days later, plates were viewed on an inverted phase-contrast microscope and growth-positive wells were scored. Clones were selected from sets ofwells plated at the same cell density, wherein >37% were growth negative. Clonal supernatant samples were assayed and appropriate clones were expanded. Subclones were obtained in exactly the same manner.
Hybridoma Growth In Vivo. BALB/c mice were injected intraperitoneally with 0.5 ml of pristane. Two weeks later, they were irradiated with 600 rads (1 rad = 0.01 gray) from a cesium source and injected intraperitoneally with 8-10 X 106 hybridoma cells. Ascitic fluid was collected in heparin-coated glass tubes; the fluid was centrifuged, divided into aliquots, and stored at -590C.
Ouchterlony Gel Diffusion. Gel diffusion was carried out on agar-coated microscope slides (37) .
RESULTS
Antiserum was produced in (A.TH X B10. HTT)F1 mice against concanavalin A-activated A.TL thymocyte blasts. This antiserum lysed 52 + 4% of A.TL lymph node cells. A.TL mice differ from recipient F1 mice at I-A, I-B, and I-J (Table 1) . I-Ak_ controlled molecules were studied by using B1O.A(4R) target cells ( Table 1 ). The antiserum lysed most BlO.A(4R) B cells (74 ± 5%) and a substantial number of B10.A(4R) T cells (39 ± 7%; Fig. 1 ). Autoantibodies were not detected. It is not clear from this result whether T cell-reactive and B cell-reactive antibodies are overlapping or distinct populations.
Exhaustive B lymphocyte absorption left antibodies that react only with a T lymphocyte subpopulation (11 ± 2%) (Fig.  2) . Exhaustive T cell absorption removed T cell-and B cell-reactive antibodies (Fig. 2) . Thus, a minor T lymphocyte fraction expresses a cell surface structure that is not characteristic of B cells, whereas every I-Ak-encoded structure detected on B cells by this particular antiserum is also expressed on T cells. Although the percentage of resting T lymphocytes expressing the (Fig. 3) . In a reciprocal absorption experiment, T cells removed B cell-reactive antibodies (Fig. 3) . We conclude that in the b haplotype as well as the k haplotype, T lymphocytes express an I-A-encoded surface molecule that is distinct from molecules on B cells.
Because analysis of minor cell populations using absorbed antiserum is technically difficult, we produced T cell-specific monoclonal antibodies that recognize the I-A-encoded structure. We developed a fluorescent ELISA to screen antibodyproducing hybridoma clones. In this microassay, T cells are in- in medium with hypoxanthine, aminopterin, and thymidine (36) . Among 1,920 hybridoma cultures examined, 43 antibodyproducing cultures specific for CBA/J but not A.TH T cells were identified; 7 were cloned, and 36 were frozen. Clonal supernatants were screened on CBA/J, BlO.A(4R), BlO.S(9R), and A.TH or A.SW T cells (ELISA), and on CBA/J B cells (microcytotoxicity assay). Nine clones were selected; these secreted antibodies that bound to CBA/J and BlO.A(4R) T cells but not to BlO.S(9R), A.TH T, or CBA/J B cells. Subelones were obtained and screened; eight subclones from three independent clones were characterized ( Table 2 ). Clonal supernatants contained antibodies that bound to CBA/J, BlO.BR, and AQR T cells but not to A.TH, A.SW, or B1O.S(9R) T cells (ELISA). Moreover, all lysed between 7% and 26% of AQR or CBA/J T cells, whereas none lysed AQR or C57BL/6-H-2k B cells (Table 2) . That these monoclonal antibodies do not bind to B cells was confirmed by absorption. Unabsorbed CC4. IH9. ID9 supernatant lysed B10. A(4R) T cells (11 ± 2%); after exhaustive B cell absorption, T cell reactivity remained (13 ± 2%). We conclude that these monoclonal antibodies bind to a T cell structure that is not characteristic of B cells. Recombinant strains were examined to map the specificity detected by the monoclonal antibodies (Table 3) . Between 10% and 22% ofC57BL/6-H-2k T cells were lysed, C57BL/6 T cells were not, placing the relevant gene within H-2. BlO.A(4R) T cells were also lysed (5-19%) , mapping the gene to the left of I-B. Finally, A.TL T cells were lysed (12-23%), whereas A.TH T cells were not, positioning the gene to the right of K. The T cell-specific determinant is controlled by an I-A subregion gene.
Three AD4. IE7 subclones were grown as ascites tumors.
Ascites fluids contained I-Ak T cell-specific antibodies that lysed AQR T cells (17-22%) at a 1:6,250 dilution. None lysed B cells. When tested with heavy chain-specific rabbit anti-mouse antibodies each appeared to be IgG3. CC4. IH9 subclones are also IgG3, whereas GC.LIDll subclones are IgG2a antibodies. (11) . These polypeptides occur on B cells (8) (9) (10) (11) . Because The I-A subregion-controlled T cell molecule belongs to a family of I-region gene products expressed on T but not B lymphocytes (20, 23-25, 27, 28 ). An I-J gene product has been designated Iat. W40 (20, 24) . Kanno and coworkers isolated monoclonal, I-J-specific antibodies that bind to a T cell hybridoma (27) . Waltenbaugh used a functional assay to isolate monoclonal antibodies specific for I-J determinants (28 (38) (39) (40) . Perhaps more than one immunoregulatory mechanism may be ascribed to Ir genes. Tat molecules may participate in regulatory cell interactions involving T cells either di- IE10  IG10  IIF9  IE7  IE12  IID9  IG7  IIG9 C57BL/6-H-2k rectly or through secreted T cell products. These interactions might be considered a second mechanism whereby Ir genes influence immunity. In this context, suppression by I-J-positive T cells or mediators would be a manifestation of Ir gene function. We believe it likely that the I-A T cell structure identified in this report will distinguish helper T cells (19, 23, 26) . Conceptually, the existence of I-region-encoded structures on T lymphocytes, divided genetically into distinct subregions and functionally into helper and suppressor cell determinants, strengthens the potential link between Iat molecules and T lymphocyte immune response function.
